Results 211 to 220 of about 88,056,303 (299)
Cerebellar hemangioblastoma in a patient with neurofibromatosis type 1: A case report. [PDF]
Stefanoni Galeazzi D +1 more
europepmc +1 more source
Objective We employed global genetic deletion of CD14 and intra‐articular CD14 blockade across multiple murine osteoarthritis (OA) models that vary in severity of pathology and rate of progression to test the hypothesis that CD14 inhibition attenuates synovial inflammation and associated pain during disease progression.
Kevin G. Burt +18 more
wiley +1 more source
Risk in Repose: Sedentary Behavior and Genetic Susceptibility to Cardiovascular Disease
James Sawalla Guseh, Ezimamaka C. Ajufo
doaj +1 more source
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics. [PDF]
Cree IA +18 more
europepmc +1 more source
ANK1 and EPB41 Variants and The Risk of Glucocorticoid‐Induced Osteonecrosis
Objective Steroid‐induced osteonecrosis of the femoral head (SONFH) is a refractory skeletal disorder influenced by genetic and environmental factors. However, conclusive pathogenic genetic evidence remains elusive due to the limited exploration of rare damaging variants. In this study, we aimed to identify rare variants associated with SONFH.
Shengbao Chen +21 more
wiley +1 more source
T cells, the Next Big Target in Axial Spondyloarthritis?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley +1 more source
The germline landscape of pituitary adenomas: established and emerging predisposition genes.
Mignone E +4 more
europepmc +1 more source
Outcomes of 'in-house' genetic testing within a specialist hereditary colorectal cancer registry. [PDF]
Srisuttayasathien M +6 more
europepmc +1 more source
From Interferon Signature to the Clinical Landscape: Type I Interferonopathies
Objective TypeI interferonopathies are heterogeneous diseases driven by dysregulated type I interferon (IFN‐I) signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. The aim of this study was to characterize the clinical, immunologic, genetic, molecular profiles of patients with suspected ...
Ismail Yaz +13 more
wiley +1 more source

